Differential enzymatic fragmentation by whole genome amplification

• US 8,088,581 B2
• Filed: 10/10/2008
• Issued: 01/03/2012
• Est. Priority Date: 03/02/2004
• Status: Active Grant

• Current Assignee: Orion Genomics LLC
• Original Assignee: Orion Genomics LLC
• Inventors: Lakey, Nathan D., Jeddeloh, Jeffrey A., Korshunova, Yulia
• Primary Examiner(s): Chunduru, Prabha
• Application Number:
  US12/287,725
• Publication Number:
  US 20110076726A1
• Time in Patent Office: 1,180 Days
• Field of Search: 435/6, 435/91.2, 536/22.1
• US Class Current: 435/6.12
• CPC Class Codes: C12Q 1/6858 Allele-specific amplification
• CPC Class Codes: C12Q 2521/331 Methylation site specific nuclease
• CPC Class Codes: C12Q 2525/155 incorporating/generating a new priming site

Abstract

The present invention provides methods for detecting the presence of methylation at a locus within a population of nucleic acids.

Claims

1. A method of amplifying unmethylated or methylated DNA fragments in a biological sample, the method comprising:

(a) providing randomly fragmented DNA from the biological sample;

(b) adding a sequence tag onto at least one end of the DNA fragments, thereby generating modified DNA fragments;

(c) digesting the modified DNA fragments with a methylation-dependent restriction enzyme under conditions where the resulting number of intact modified DNA fragments is inversely proportional to the methylation density of the locus or a methylation-sensitive restriction enzyme under conditions where the resulting number of intact modified DNA fragments is directly proportional to the methylation density of the locus to obtain intact modified DNA fragments and digested DNA fragments; and

(d) after the digesting step, amplifying the intact modified DNA fragments with at least one primer that initiates amplification from the sequence tags, thereby generating amplified intact DNA fragments representing the unmethylated or methylated modified intact DNA fragments in the sample.

2. The method of claim 1, comprising randomly fragmenting DNA from the biological sample before the adding step.

3. The method of claim 1, wherein the adding step comprises ligating the sequence tag to at least one end of the DNA fragments.

4. The method of claim 1, wherein the sequence tags comprise synthetic molecules that exhibit base pairing.

5. The method of claim 4, wherein the synthetic molecules are selected from the group consisting of peptide nucleic acids and intercalating nucleic acids.

6. The method of claim 1, wherein the adding step comprises adding a homopolymeric sequence tag to at least one of the ends of the DNA fragments with terminal transferase.

7. The method of claim 1, wherein the digesting step comprises digesting the fragmented DNA with a methylation-sensitive restriction enzyme;

and the amplifying step comprises amplifying intact modified fragments having the same sequence as the methylated DNA in the sample.

8. The method of claim 1, wherein the digesting step comprises digesting the fragmented DNA with a methylation-dependent restriction enzyme;

and the amplifying step comprises amplifying intact modified fragments having the same sequence as the unmethylated DNA in the sample.

9. The method of claim 1, wherein the amplifying step comprises the polymerase chain reaction.

10. The method of claim 1, wherein the amplifying step comprises rolling circle amplification or branched chain amplification.

11. The method of claim 1, wherein the amplification is linear.

12. The method of claim 1, wherein the method comprises quantifying the number of amplified intact DNA fragments comprising a particular sequence.

13. The method of claim 12, wherein the quantifying step comprises hybridizing the amplified intact DNA to a quantifying polynucleotide.

14. The method of claim 13, wherein the quantifying polynucleotide comprises synthetic molecules that exhibit base pairing.

15. The method of claim 14, wherein the synthetic molecules are selected from the group consisting of peptide nucleic acids and intercalating nucleic acids.

16. The method of claim 13, wherein the quantifying step is performed after the amplifying step and the quantifying step comprises detecting copies of a locus with hybrid capture.

17. The method of claim 13, wherein the quantifying polynucleotide is used in a quantitative amplification step.

18. The method of claim 13, wherein the quantifying polynucleotide is attached to a solid support.

19. The method of claim 13, wherein, before the amplifying step, the DNA fragments are contacted with an agent that modifies unmethylated cytosines but does not modify methylated cytosines;

and the quantifying step comprises hybridizing a polynucleotide to amplified intact DNA where the polynucleotide hybridizes to the converted sequence.

20. The method of claim 1, further comprising sequencing the amplified intact DNA fragments.

21. The method of claim 1, wherein the method further comprises cloning the amplified DNA to make a library of sequences representing the unmethylated or methylated DNA in the sample.

22. The method of claim 1, wherein the methylation is at the C5 position of a cytosine within the locus.

23. The method of claim 8, wherein the methylation-dependent restriction enzyme is McrBC.